HLA-E and atrial fibrillation: Similarly, 12/56 individuals appear to have a loss of expression of HLA-E. Tables S1C–F also show the ratio of average expression in affected (AF) versus unaffected (UN) at each time point and average expression in individuals with a positive or a negative polygenic risk score (PRS) (see Table S1A) regardless of disease status.